{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:45:31Z","timestamp":1761763531434,"version":"3.44.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1067\/mhj.2000.111611","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:20:13Z","timestamp":1027556413000},"page":"S90-S102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"S","title":["Importance of microembolization and inflammation in atherosclerotic heart disease"],"prefix":"10.1067","volume":"140","author":[{"given":"David M.","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Topol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2000.111611_BIB1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/hrt.50.2.127","article-title":"Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi","volume":"50","author":"Falk","year":"1983","journal-title":"Br Heart J"},{"key":"10.1067\/mhj.2000.111611_BIB2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(97)09032-6","article-title":"Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men","volume":"351","author":"Ridker","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mhj.2000.111611_BIB3","first-page":"588","article-title":"Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response","volume":"61","author":"Le","year":"1989","journal-title":"Lab Invest"},{"key":"10.1067\/mhj.2000.111611_BIB4","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.179.4.1253","article-title":"Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees","volume":"179","author":"van der Poll","year":"1994","journal-title":"J Exp Med"},{"key":"10.1067\/mhj.2000.111611_BIB5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.94.5.874","article-title":"Elevated levels of interleukin-6 in unstable angina","volume":"94","author":"Biasucci","year":"1996","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0002-8703(93)90526-F","article-title":"Elevated plasma interleukin-6 levels in patients with acute myocardial infarction","volume":"126","author":"Miyao","year":"1993","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2000.111611_BIB7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(81)91565-8","article-title":"C-reactive protein fifty years on","volume":"1","author":"Pepys","year":"1981","journal-title":"Lancet"},{"key":"10.1067\/mhj.2000.111611_BIB8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1440-1827.1995.tb03515.x","article-title":"Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method","volume":"45","author":"Hatanaka","year":"1995","journal-title":"Pathol Int"},{"key":"10.1067\/mhj.2000.111611_BIB9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.95.1.97","article-title":"C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction","volume":"95","author":"Lagrand","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.111611_BIB11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9149(98)00370-1","article-title":"Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina","volume":"82","author":"Gaspardone","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB12","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","article-title":"C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction","volume":"31","author":"Morrow","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/01.CIR.99.7.855","article-title":"Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability","volume":"99","author":"Biasucci","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB14","doi-asserted-by":"crossref","first-page":"459, 61,A9","DOI":"10.1016\/S0002-9149(99)00333-1","article-title":"Elevated levels of Creactive protein before coronary artery bypass grafting predict recurrence of ischemic events","volume":"84","author":"Milazzo","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB15","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0002-9149(99)00162-9","article-title":"C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction","volume":"83","author":"Tommasi","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB16","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.97.20.2007","article-title":"C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB17","doi-asserted-by":"crossref","first-page":"1263, 5,A9","DOI":"10.1016\/S0002-9149(99)00068-5","article-title":"Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial","volume":"83","author":"Sajadieh","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB18","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/01.CIR.91.7.1914","article-title":"Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells","volume":"91","author":"Weber","year":"1995","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.111611_BIB20","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1177\/106002809703101210","article-title":"Current perspective on the use of angiotensin-converting enzyme inhibitors in the management of coronary (atherosclerotic) artery disease","volume":"31","author":"Cheng","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1067\/mhj.2000.111611_BIB21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","article-title":"Long-term effects of pravastatin on plasma concentration of C-reactive protein","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0735-1097(97)00537-8","article-title":"Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys","volume":"31","author":"Williams","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB24","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/01.CIR.89.5.2462","article-title":"A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"89","author":"Stary","year":"1994","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/hrt.69.5.377","article-title":"Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content","volume":"69","author":"Davies","year":"1993","journal-title":"Br Heart J"},{"issue":"Suppl E","key":"10.1067\/mhj.2000.111611_BIB26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/eurheartj\/11.suppl_E.3","article-title":"The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life","volume":"11","author":"Stary","year":"1990","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2000.111611_BIB27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.CIR.90.2.775","article-title":"Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture","volume":"90","author":"Moreno","year":"1994","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB28","first-page":"463","article-title":"Fibrous and lipid-rich atherosclerotic plaques are part of interchangeable morphologies related to inflammation: a concept","volume":"5","author":"van der Wal","year":"1994","journal-title":"Coron Artery Dis"},{"key":"10.1067\/mhj.2000.111611_BIB29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0021-9150(87)90198-5","article-title":"Increased subendothelial infiltration of the coronary arteries with monocytes\/macrophages in patients with unstable angina. Histological data on 14 autopsied patients","volume":"68","author":"Sato","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1067\/mhj.2000.111611_BIB30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/01.CIR.71.4.709","article-title":"Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy","volume":"71","author":"Kohchi","year":"1985","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB31","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/01.CIR.99.19.2503","article-title":"Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques","volume":"99","author":"Sukhova","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB32","first-page":"1565","article-title":"Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture","volume":"92","author":"Shah","year":"1995","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.CIR.89.1.36","article-title":"Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology","volume":"89","author":"van der Wal","year":"1994","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/hrt.80.1.14","article-title":"Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes","volume":"80","author":"van der Wal","year":"1998","journal-title":"Heart"},{"key":"10.1067\/mhj.2000.111611_BIB36","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.86.3.790","article-title":"Transient intermittent lymphocyte activation is responsible for the instability of angina","volume":"86","author":"Serneri","year":"1992","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB37","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1161\/01.CIR.99.15.1965","article-title":"Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter","volume":"99","author":"Stefanadis","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/01.CIR.93.2.229","article-title":"Platelet function in acute myocardial infarction treated with direct angioplasty","volume":"93","author":"Gawaz","year":"1996","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB39","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/01.CIR.92.7.1693","article-title":"Increased soluble form of P-selectin in patients with unstable angina","volume":"92","author":"Ikeda","year":"1995","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB40","first-page":"H1049","article-title":"Thrombin receptor peptide-mediated leukocyte rolling in rat mesenteric venules: roles of P-selectin and sialyl Lewis X","volume":"267","author":"Zimmerman","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1067\/mhj.2000.111611_BIB41","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1073\/pnas.91.19.8767","article-title":"P-selectin induces the expression of tissue factor on monocytes","volume":"91","author":"Celi","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mhj.2000.111611_BIB42","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/359848a0","article-title":"Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets","volume":"359","author":"Palabrica","year":"1992","journal-title":"Nature"},{"key":"10.1067\/mhj.2000.111611_BIB43","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.CIR.100.6.614","article-title":"Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes","volume":"100","author":"Aukrust","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"10.1067\/mhj.2000.111611_BIB45","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.4049\/jimmunol.155.10.4917","article-title":"Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes","volume":"155","author":"Kiener","year":"1995","journal-title":"J Immunol"},{"key":"10.1067\/mhj.2000.111611_BIB46","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/01.CIR.96.2.396","article-title":"Activation of monocyte\/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor","volume":"96","author":"Mach","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB47","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1055\/s-0037-1615114","article-title":"CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity","volume":"79","author":"Zhou","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2000.111611_BIB48","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/01.RES.81.3.448","article-title":"Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?","volume":"81","author":"Schonbeck","year":"1997","journal-title":"Circ Res"},{"key":"10.1067\/mhj.2000.111611_BIB49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.178.2.669","article-title":"CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40","volume":"178","author":"Alderson","year":"1993","journal-title":"J Exp Med"},{"key":"10.1067\/mhj.2000.111611_BIB50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1152\/physrev.1989.69.1.58","article-title":"Molecular mechanisms of platelet activation","volume":"69","author":"Siess","year":"1989","journal-title":"Physiol Rev"},{"key":"10.1067\/mhj.2000.111611_BIB51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-2952(90)90699-L","article-title":"Amplification of platelet response during acute inflammation in rats","volume":"40","author":"Srivastava","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1067\/mhj.2000.111611_BIB52","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.CIR.73.3.418","article-title":"Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death","volume":"73","author":"Davies","year":"1986","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0002-9149(78)90983-9","article-title":"Nonobstructive coronary thrombosis in sudden cardiac death","volume":"42","author":"Frink","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/hrt.59.2.196","article-title":"Coronary thrombosis and platelet\/fibrin microemboli in death associated with acute myocardial infarction","volume":"59","author":"Frink","year":"1988","journal-title":"Br Heart J"},{"key":"10.1067\/mhj.2000.111611_BIB55","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.71.4.699","article-title":"Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and\/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion","volume":"71","author":"Falk","year":"1985","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB56","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0735-1097(85)80381-8","article-title":"Scintigraphic evidence of the \u2033no reflow\u201d phenomenon in human beings after coronary thrombolysis","volume":"5","author":"Schofer","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB57","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0735-1097(94)90290-9","article-title":"Progressive decreases in coronary vein flow during reperfusion in acute myocardial infarction: clinical documentation of the no reflow phenomenon after successful thrombolysis","volume":"24","author":"Komamura","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB58","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0735-1097(98)00435-5","article-title":"Assessment of \u2033microvascular no-reflow phenomenon\u201d using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction","volume":"32","author":"Kondo","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.93.2.223","article-title":"Clinical implications of the \u2033no reflow\u201d phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction","volume":"93","author":"Ito","year":"1996","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/10408369209105245","article-title":"Cardiac troponin T in the diagnosis of myocardial injury","volume":"29","author":"Mair","year":"1992","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1067\/mhj.2000.111611_BIB61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/clinchem\/46.3.338","article-title":"Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology","volume":"46","author":"Ooi","year":"2000","journal-title":"Clin Chem"},{"key":"10.1067\/mhj.2000.111611_BIB62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0379-0738(98)00193-5","article-title":"Evaluation of cardiac troponin I immunoreaction in autopsy hearts: a possible marker of early myocardial infarction","volume":"99","author":"Hansen","year":"1999","journal-title":"Forensic Sci Int"},{"key":"10.1067\/mhj.2000.111611_BIB63","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJM199905273402103","article-title":"Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina","volume":"340","author":"Hamm","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.111611_BIB64","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(99)10285-X","article-title":"Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban","volume":"354","author":"Heeschen","year":"1999","journal-title":"Lancet"},{"key":"10.1067\/mhj.2000.111611_BIB65","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0735-1097(97)00506-8","article-title":"Myonecrosis after revascularization procedures","volume":"31","author":"Califf","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB66","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0735-1097(10)80174-3","article-title":"Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty","volume":"17","author":"Klein","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB67","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/0002-8703(85)90343-6","article-title":"Creatine kinase release after successful percutaneous transluminal coronary angioplasty","volume":"109","author":"Oh","year":"1985","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2000.111611_BIB68","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0002-9149(87)91145-3","article-title":"Changes in myoglobin, creatine kinase and creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris","volume":"59","author":"Pauletto","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB69","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/euhj.1997.0732","article-title":"Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements","volume":"19","author":"Johansen","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2000.111611_BIB70","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9149(99)80144-1","article-title":"Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty","volume":"76","author":"Karim","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB71","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0735-1097(95)00371-1","article-title":"Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina","volume":"26","author":"Rupprecht","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB72","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.101.5.570","article-title":"Recognition of the importance of embolization in atherosclerotic vascular disease","volume":"101","author":"Topol","year":"2000","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB73","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0735-1097(98)00659-7","article-title":"Influence of a platelet GPIIb\/IIIa receptor antagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocardial Tc-99m sestamibi scintigraphy","volume":"33","author":"Koch","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB74","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM199610313351801","article-title":"Cardiac troponin T levels for risk stratification in acute myocardial ischemia","volume":"335","author":"Ohman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.111611_BIB75","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.111611_BIB76","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jama.1997.03540300029029","article-title":"Prognostic implication of creatine kinase elevation following elective coronary artery interventions","volume":"277","author":"Kong","year":"1997","journal-title":"JAMA"},{"key":"10.1067\/mhj.2000.111611_BIB77","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/clc.4960220403","article-title":"Periprocedural creatine kinase-MB elevations: long-term impact and clinical implications","volume":"22","author":"Adgey","year":"1999","journal-title":"Clin Cardiol"},{"key":"10.1067\/mhj.2000.111611_BIB78","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/01.CIR.94.7.1528","article-title":"Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions","volume":"94","author":"Abdelmeguid","year":"1996","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB79","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/01.CIR.97.8.765","article-title":"Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction","volume":"97","author":"Wu","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB80","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1161\/01.CIR.98.24.2695","article-title":"Effect of glycoprotein IIb\/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction","volume":"98","author":"Neumann","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB81","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS)","volume":"338","author":"Study Investigators","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.111611_BIB82","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM)","volume":"338","author":"Study Investigators","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.111611_BIB83","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","volume":"339","author":"The PURSUIT Trial Investigators","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.111611_BIB84","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mhj.2000.111611_BIB85","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(98)11086-3","article-title":"Platelet GPIIb-IIIa blockers","volume":"353","author":"Topol","year":"1999","journal-title":"Lancet"},{"key":"10.1067\/mhj.2000.111611_BIB86","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty","volume":"330","author":"The EPIC Investigators","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.111611_BIB87","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","author":"The EPILOG Investigators","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.111611_BIB88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade","volume":"352","author":"The EPISTENT Investigators","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mhj.2000.111611_BIB89","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(99)10018-7","article-title":"Outcomes at 1 year and economic implication of platelet glycoprotein IIb\/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial","volume":"354","author":"Topol","year":"1999","journal-title":"Lancet"},{"key":"10.1067\/mhj.2000.111611_BIB90","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1997.03550060055036","article-title":"Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention","volume":"278","author":"Topol","year":"1997","journal-title":"JAMA"},{"key":"10.1067\/mhj.2000.111611_BIB91","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1161\/01.CIR.100.25.2477","article-title":"Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb\/IIIa inhibitor for stenting trial) diabetic substudy","volume":"100","author":"Marso","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB92","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/01.CIR.101.24.2788","article-title":"Trial of abciximab with and without low-dose reteplase for acute myocardial infarction","volume":"101","author":"The Strategies for Patency Enhancement in the Emergency Department (SPEED) Group","year":"2000","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB93","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/01.CIR.99.21.2720","article-title":"Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial","volume":"99","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB94","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.95.4.846","article-title":"Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb\/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo- controlled, dose-ranging trial","volume":"95","author":"Ohman","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.111611_BIB95","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1055\/s-0038-1657620","article-title":"GPIIb\/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab","volume":"78","author":"Coller","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2000.111611_BIB96","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-0037-1615850","article-title":"Binding of abciximab to alpha V beta 3 and activated alpha M beta 2 receptors: with a review of platelet-leukocyte interactions","volume":"82","author":"Coller","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2000.111611_BIB97","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.97.17.1680","article-title":"Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb\/IIIa receptor blockade","volume":"97","author":"Mascelli","year":"1998","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870300033901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870300033901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:04:17Z","timestamp":1757567057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870300033901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S0002870300033901"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2000.111611","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2000,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Importance of microembolization and inflammation in atherosclerotic heart disease","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mhj.2000.111611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}